Skip to main content

Table 1 Clinical and demographic characteristics of all individuals included in the study

From: Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients

Groups Age (Years) Mean ± SD Gender - n (%) PVL Spasticity in lower limbs Overactive bladder
F M Median (IQR 25–75) n (%) n (%)
HAM/TSP (n = 20) 48.7 ± 10 13 (65.0) 7 (35.0) 173,146 (94,232-240,393)* 20 (100) 13 (76)a
AS (n = 28) 42.9 ± 11.4 19 (67.9) 9 (32.1) 10,101 (1659-36,326) 0 0
CTR (n = 18) 41.4 ± 14.2 10 (55.6) 8 (44.4) 0 0
  1. HAM/TSP HTLV-1-associated myelopathy/Tropical spastic paraparesis, AS Asymptomatic, CTR Uninfected controls, n Number, SD Standard Deviation, F Female, M Male, IQR Interquartile range, PVL HTLV-1 Proviral load (copies/106 PBMC), performed for 14 patients with HAM/TSP and 24 asymtomatic individuals. aData available from only 17 HAM/TSP patients. Statistical analysis of differences between groups determined by the Kruskal-Wallis test, followed by Dunn’s post-test. Statistical analysis of proviral load performed using the Mann-Whitney test. *(p = 0.0001)